Skip to content

Clinical Application of Cross-education During Stroke Rehabilitation

Clinical Application of Cross-education During Stroke Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02948725
Acronym
X-Ed-Stroke01
Enrollment
13
Registered
2016-10-28
Start date
2016-11-30
Completion date
2022-12-31
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Based on the current state of knowledge and gaps in the literature we will conduct an intervention study to explore novel treatment and rehabilitation of patients at Royal University Hospital (RUH) with motor deficits following stroke. This project has the following objectives: 1. To determine if cross-education, in addition to standard rehabilitation leads to better recovery of upper limb function for stroke patients with hemiparesis. 2. To incorporate functional brain activation as measured by functional magnetic resonance imaging (fMRI) to examine the neural mechanisms associated with changes in motor function of the paretic arm post-stroke. 3. To use diffusion tensor imaging (DTI) tractography to measure connectivity and examine the extent to which white matter tract thickness correlates with preserved motor output in patients post-stroke.

Interventions

OTHERCross-education + standard rehabilitation

Sponsors

Saskatchewan Health Research Foundation
CollaboratorOTHER
Royal University Hospital Foundation
CollaboratorOTHER
University of Saskatchewan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * within 18 months of stroke recovery * medically stable * ambulatory * have moderate to severe upper limb hemiparesis as diagnosed by clinicians * Consent

Exclusion criteria

* significant cognitive impairment or aphasia affecting understanding, as assessed by clinician * severe upper limb spasticity preventing any movement of the proximal arm and shoulder * diagnosis of hemorrhagic or bilateral stroke * history of other severe upper limb musculoskeletal injury * other neurological diseases * intracranial metal clips or cardiac pacemaker, or anything that would preclude an MRI * Any condition that would preclude the participant's ability to attend follow-up visits in the opinion of the Investigator

Design outcomes

Primary

MeasureTime frame
Motor function scores as assessed using the Fugl-Meyer AssessmentAt 26 weeks

Secondary

MeasureTime frame
grip and wrist strengthAt 26 weeks
volume of motor cortex activationAt 26 weeks

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026